Synchronoss Showcases Expanded Personal Cloud Platform, Capsyl Momentum, and Previews New Offering at CES 2026 Advancing Personal Cloud Capabilities for Operators and Consumers GlobeNewswire January 06, 2026 BRIDGEWATER, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), a global leader and innovator in personal cloud solutions, today announced expanded capabilities across […]

Gabelli Launches Sports-Focused ETF: GOLS – Gabelli Opportunities in Live and Sports An actively managed ETF built to capture the enduring value of sports and live entertainment GlobeNewswire January 06, 2026 GREENWICH, Conn., Jan. 06, 2026 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”), today announced the launch of GOLS on the NYSE. GOLS is an

Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome GlobeNewswire January 06, 2026 First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across multiple sites Reached written alignment with FDA on inclusion of greater-than or equal to3 months

The Chefs' Warehouse, Inc. to Participate in the ICR Conference GlobeNewswire January 06, 2026 RIDGEFIELD, Conn., Jan. 06, 2026 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today announced that the Company will participate

Compass Therapeutics Provides Corporate Update GlobeNewswire January 06, 2026 The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC). In the ongoing Phase 1 dose-escalation study

Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency GlobeNewswire January 06, 2026 European decision on approval is expected by Q1 2027 If approved, etripamil nasal spray is expected to offer patients a safe and effective self-administered treatment option for PSVT outside of the healthcare

Icon Energy Corp. Announces Reverse Stock Split GlobeNewswire January 06, 2026 ATHENS, Greece, Jan. 06, 2026 (GLOBE NEWSWIRE) — Icon Energy Corp. (“Icon” or the “Company“) (Nasdaq: ICON), an international shipping company providing worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that its board of directors (the

Terrestrial Energy Executes DOE Agreement for Project TETRA Under Advanced Reactor Pilot Program GlobeNewswire January 06, 2026 OTA agreement provides for construction and operation of Project TETRA, Terrestrial Energy's pilot reactor using Integral Molten Salt Reactor technology Terrestrial Energy now positioned to move quickly from design to operation under DOE authorization, laying the groundwork for

Provident Bank Annual Economic Outlook Survey: Business Owners Shift from Passive Optimism in 2025 to Active Investment in 2026 Findings reveal businesses are poised to accelerate, with significant projected increases in capital spending, hiring, and AI adoption GlobeNewswire January 06, 2026 ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based

XBP Global Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire January 06, 2026 IRVING, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process